Literature DB >> 25335486

Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK: a round table discussion.

David R Thickett1, Clare Kendall2, Lisa G Spencer3, Nick Screaton4, William A Wallace5, Hilary Pinnock6, Julia Bott7, Lucy Pigram8, Sarah Watson9, Ann B Millar10.   

Abstract

This article is the result of a round table discussion held at BMA House. Its purpose is to outline the challenges facing both patients and doctors in managing idiopathic pulmonary fibrosis. A number of recommendations for service development and research have been identified. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis; Not Applicable

Mesh：

Year:  2014        PMID： 25335486     DOI： 10.1136/thoraxjnl-2014-206284

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  14 in total

Review 1.  Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

Authors:  Mirjam J G van Manen; J J Miranda Geelhoed; Nelleke C Tak; Marlies S Wijsenbeek
Journal:  Ther Adv Respir Dis       Date:  2017-01-01       Impact factor: 4.031

2.  The need for patient-centred clinical research in idiopathic pulmonary fibrosis.

Authors:  Anne-Marie Russell; Mirjam A G Sprangers; Steven Wibberley; Noel Snell; Daniel M Rose; Jeff J Swigris
Journal:  BMC Med       Date:  2015-09-24       Impact factor: 8.775

3.  Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.

Authors:  Domokos Bartis; Louise E Crowley; Vijay K D'Souza; Lee Borthwick; Andrew J Fisher; Adam P Croft; Judit E Pongrácz; Richard Thompson; Gerald Langman; Christopher D Buckley; David R Thickett
Journal:  BMC Pulm Med       Date:  2016-04-14       Impact factor: 3.317

4.  Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.

Authors:  Tomonori Makiguchi; Mitsuhiro Yamada; Yusuke Yoshioka; Hisatoshi Sugiura; Akira Koarai; Shigeki Chiba; Naoya Fujino; Yutaka Tojo; Chiharu Ota; Hiroshi Kubo; Seiichi Kobayashi; Masaru Yanai; Sanae Shimura; Takahiro Ochiya; Masakazu Ichinose
Journal:  Respir Res       Date:  2016-09-05

5.  Bleomycin (BLM) Induces Epithelial-to-Mesenchymal Transition in Cultured A549 Cells via the TGF-β/Smad Signaling Pathway.

Authors:  Kui-Jun Chen; Qing Li; Cang-Mei Wen; Zhao-Xia Duan; Jie Yuan Zhang; Chuan Xu; Jian-Min Wang
Journal:  J Cancer       Date:  2016-07-09       Impact factor: 4.207

6.  What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany.

Authors:  Mirjam J G van Manen; Michael Kreuter; Bernt van den Blink; Ute Oltmanns; Karin Palmowski; Eva Brunnemer; Simone Hummler; Nelleke C Tak; Leon van den Toorn; Jelle Miedema; Henk C Hoogsteden; Marlies S Wijsenbeek
Journal:  ERJ Open Res       Date:  2017-02-14

7.  Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary care.

Authors:  David Thickett; Jaco Voorham; Ronan Ryan; Rupert Jones; Robina Coker; Andrew M Wilson; Sen Yang; Mandy Yl Ow; Priyanka Raju; Isha Chaudhry; Antony Hardjojo; Victoria Carter; David B Price
Journal:  BMJ Open       Date:  2020-05-30       Impact factor: 2.692

8.  Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.

Authors:  Martin Kolb; Luca Richeldi; Jürgen Behr; Toby M Maher; Wenbo Tang; Susanne Stowasser; Christoph Hallmann; Roland M du Bois
Journal:  Thorax       Date:  2016-09-26       Impact factor: 9.139

9.  An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis.

Authors:  Evans R Fernández Pérez; Pearlanne Zelarney; Shirley Thomas; Deborah A Shoop; Jessica L Munson; Kelsey D Johnson; Matthew E Stern; Sarah Meadows
Journal:  ERJ Open Res       Date:  2018-02-16

10.  Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK.

Authors:  Helen Strongman; Imran Kausar; Toby M Maher
Journal:  Adv Ther       Date:  2018-04-11       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.